Nav: Home

Ultraviolet air sterilizer reduces sepsis and mortality in cardiac surgery patients

October 16, 2016

Lisbon, Portugal - 16 October 2016: An ultraviolet air steriliser reduces sepsis and mortality in cardiac surgery patients, according to research presented today at Acute Cardiovascular Care 2016.1

"Hospital-acquired infections are the most common postoperative complication in the intensive care unit (ICU) and are associated with longer hospital stay, higher mortality rates, and increased healthcare costs," said lead author Dr Juan Bustamante Munguira, a physician at the University Hospital La Princesa in Madrid, Spain.

He continued: "Pathogens are transmitted through the air, and by touching skin, clothes, and medical instruments and devices. Several studies have shown that standard cleaning methods are not effective for killing pathogens. Novel disinfection technologies, such as hydrogen peroxide vapour, ozone mists, or ultra microfibre cloths, have emerged to solve this situation."

This prospective, randomised and non-interventional clinical trial evaluated the impact of an ultraviolet air steriliser on clinical outcomes of patients in ICU who had undergone cardiac surgery. The study included 1097 patients, who were randomised to an ICU with (522 patients) or without (575 patients) the steriliser.

Patients were 68 years of age on average and 67% were men. EuroSCORE2 before surgery was similar between groups (6.90 in patients with the steriliser and 7.02 in those without), which indicates that they had the same risk of dying during or shortly after heart surgery.

The investigators found that sepsis occurred in 3.4% of patients using the steriliser compared to 6.7% patients not using the steriliser (p = 0.02). The 30 day in-hospital mortality rate was significantly lower in patients using the ultraviolet air steriliser (3.8%) compared to the group without it (6.4%).

Dr Bustamante Munguira said: "Sepsis, also called blood poisoning, can be caused by an infection and is potentially life-threatening. We found lower rates of sepsis and mortality in patients who recovered from cardiac surgery in an ICU fitted with an ultraviolet air steriliser."

The incidence of ventilator-associated pneumonia was lower in the ultraviolet group but the difference between groups was not statistically significant. The length of stay in ICU and the hospital was similar in both groups.

A logistic regression model showed that age, emergency (unscheduled) surgery, and the absence of the ultraviolet air steriliser were each independently associated with 30 day in-hospital mortality.

Dr Bustamante Munguira said: "Our research shows that the ultraviolet air steriliser was independently associated with lower 30 day in-hospital mortality. The ultraviolet radiation is harmless to humans but kills microorganisms including bacteria, viruses and spores by inactivating their RNA or DNA."

He concluded: "Our research indicates that this technology may help reduce hospital infections and deaths, and larger studies may find a statistically significant benefit on pneumonia. This is a relatively new area of research and a cost effectiveness study in more patients is needed."
-end-
Authors: ESC Press Office
Tel: +33 (0)4 89 87 24 83
Email: press@escardio.org

Notes to editor

SOURCES OF FUNDING: The study was sponsored by Healthcare Research Fund (FIS, by its Spanish acronym) at Instituto de Salud Carlos III, and Health Management at the Healthcare Regional Ministry of Junta de Castilla y León.

DISCLOSURES: None.

References and notes

1Dr Bustamante Munguira will present the abstract 'An ultraviolet air sterilizer, can it be reduced the rate of infections in patients underwent to cardiac surgery?' during Poster Session 4: Cardiac surgery on 16 October at 14:00 to 17:30 in the Poster Area

2EuroSCORE stands for European System for Cardiac Operative Risk Evaluation. It uses risk factors to predict the chances of dying during or shortly after undergoing heart surgery.

About the Acute Cardiovascular Care Association

The Acute Cardiovascular Care Association (ACCA) is a registered branch of the ESC. Its mission is to improve the quality of care and outcomes of patients with acute cardiovascular diseases.

About the European Society of Cardiology

The European Society of Cardiology (ESC) represents more than 95 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

Information for journalists attending Acute Cardiovascular Care 2016

Acute Cardiovascular Care 2016 will be held 15 to 17 October in Lisbon, Portugal at the Centro de Congressos de Lisboa. The full scientific programme is available here
  • To register on-site please bring a valid press card or appropriate letter of assignment with proof of three recent published articles (cardiology or health-related, or referring to a previous ESC Event).

  • Press registration is not available to industry or its public relations representatives, event management, marketing or communications representatives.


European Society of Cardiology

Related Sepsis Articles:

Readily available drug cocktail can help prevent sepsis shock and death
Even in advanced medical settings, sepsis is still very dangerous and accounts for over 400,000 deaths annually in the US alone.
A rusty and sweet side of sepsis
A research team led by Miguel Soares at the Instituto Gulbenkian de Ciência (IGC) in Portugal discovered an unsuspected mechanism that is protective against sepsis.
New pediatric protocol reduces missed sepsis diagnoses by 76 percent
An electronic sepsis alert using a combination of vital signs, risk factors and physician judgment to identify children in a pediatric emergency department with severe sepsis reduced missed diagnoses by 76 percent.
Machine learning may help in early identification of severe sepsis
A machine-learning algorithm has the capability to identify hospitalized patients at risk for severe sepsis and septic shock using data from electronic health records (EHRs), according to a study presented at the 2017 American Thoracic Society International Conference.
Faster is better when it comes to sepsis care
An analysis covering nearly 50,000 patients from 149 New York hospitals is the first to offer scientific evidence that a controversial early sepsis care regulation worked.
Prompt sepsis treatment less likely when ERs overcrowded
According to a new study, patients with sepsis, a life-threatening complication of an infection, had delays approaching one hour in being given antibiotics when seen in emergency rooms that were overcrowded.
New test to rapidly diagnose sepsis
Researchers have developed a test that can rapidly and reliably diagnose sepsis, a potentially life-threatening complication of bacterial infections.
Children who survive sepsis often experience lingering effects
Survival rates have risen dramatically in recent years among children who develop sepsis, a severe, life-threatening immune reaction to an infection somewhere in the body.
Recognize sepsis as a separate cause of illness and death
Sepsis should be recognized as a separate cause of illness and death around the world.
Simple measures cut sepsis deaths nearly in half
Sepsis, also called blood poisoning, is a common affliction that can affect people of all ages.

Related Sepsis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Don't Fear Math
Why do many of us hate, even fear math? Why are we convinced we're bad at it? This hour, TED speakers explore the myths we tell ourselves and how changing our approach can unlock the beauty of math. Guests include budgeting specialist Phylecia Jones, mathematician and educator Dan Finkel, math teacher Eddie Woo, educator Masha Gershman, and radio personality and eternal math nerd Adam Spencer.
Now Playing: Science for the People

#518 With Genetic Knowledge Comes the Need for Counselling
This week we delve into genetic testing - for yourself and your future children. We speak with Jane Tiller, lawyer and genetic counsellor, about genetic tests that are available to the public, and what to do with the results of these tests. And we talk with Noam Shomron, associate professor at the Sackler School of Medicine at Tel Aviv University, about technological advancements his lab has made in the genetic testing of fetuses.